Unveiling the Future of Gene Therapy: Cyagen's Breakthrough in SCA3 Treatment

Join Dr. Reza Rezarei as we explore Cyagen's breakthrough in treating Spinocerebellar Ataxia Type 3 (SCA3) through gene therapy. Discover how our Humanized Genomic Ortholog for Gene Therapy (HUGO-GT) mouse model is revolutionizing research, offering hope to those affected by SCA3. Stay tuned for updates on our progress!
Artificial intelligence services provided by Cyrinn
www.cyrinn.cn/
You can find all our services on our website: www.cyagen.com
Follow us on Social Media:
RUclips: / cyagen
Twitter: / cyagenbio
Linkedin: / cyagen-biosciences
Facebook: www.facebook.c...
Email：
[e-mail] (Animal Model Services)
[e-mail] (Cyagen Catalog Models)
[e-mail] (Cell Products and Services)